Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.88B -36.4%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	n/a
PE Ratio	33.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,799
Average Volume	505,034
Open	47.00
Previous Close	46.73
Day's Range	46.36 - 47.01
52-Week Range	37.18 - 67.84
Beta	0.17
RSI	43.80
Earnings Date	Feb 12, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.